Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in Neurogenic Overactive Bladder
NCT00213577Phase 2Terminated
- Sponsor
- Rouen University Hospital
- Start
- Dec 2003
- Primary completion
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in overactive bladder (OAB), neurogenic bladder, sponsored by Rouen University Hospital. Started Dec 2003; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)neurogenic bladder
Beyond the preview
Go deeper on NCT00213577.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00213577.